The company’s losses amounted to 248 million USD, compared to a profit of 2.9 billion USD in the same period last year, while revenue increased by 3% to 15 billion USD.
Read more In Vilnius district, a man is suspected of killing his partner
After clinical trial failure, Pfizer reports losses
